Continue reading here: Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
Continue reading here: Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
Read the original: Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
More: Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
View post: Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
Original post: Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market
View original post here: INmune Bio to Participate in Baird’s Biotech Discovery Series Webcast on February 13, 2024
Go here to read the rest: Linnea SA of Switzerland and Universidade Estadual de Campinas (Unicamp) Brazil announce scientific partnership to promote cannabinoids research
More: nuEra Cannabis Becomes a Vertically Integrated Illinois Powerhouse with Ieso Acquisition
Follow this link: Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual...
Original post: Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Recent Comments